HS
Himadri Sen
About Himadri Sen
Data last updated:
Himadri Sen is a Director at Omsav Pharma Research Private Limited (since 2016). The companies operate in Pharma. Omsav Pharma Research Private Limited reported revenue of ₹14.58 Cr (FY 2025). Earlier, Himadri Sen was a Whole-Time Director at Unimark Remedies Limited (2010–2013) and Director at Steerlife India Private Limited (from 2015).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Omsav Pharma Research Private Limited U24230MH2016PTC339817 | Director | 12 Dec 2016 | 2016 | ₹14.58 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Unimark Remedies Limited U23200MH1993PLC075373 | Whole-Time Director | 21 Sep 2010 | 1993 | ₹104 Cr (FY 2019) | Active |
 Steerlife India Private Limited U24230KA2015PTC081581 | Director | 14 Jul 2015 | 2015 | ₹1.68 Cr (FY 2024) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Himadri Sen
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kewal Kundanlal Handa | 00056826 | Omsav Pharma Research Private Limited | Director |
| Om Dutt Tyagi | 01965135 | Omsav Pharma Research Private Limited | Managing Director |
| Ranchodlal Keshavlal Shah | 03470002 | Omsav Pharma Research Private Limited | Director |
| Savita Tyagi | 09439020 | Omsav Pharma Research Private Limited | Director |
| Tushar Srivastava Kumar | 02277241 | Omsav Pharma Research Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Himadri Sen
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Himadri Sen
Himadri Sen currently holds 1 directorship: Omsav Pharma Research Private Limited (Director, since 12 Dec 2016, revenue ₹14.58 Cr (FY 2025)).
Himadri Sen was first appointed on 21 Sep 2010 as Whole-Time Director at Unimark Remedies Limited. The most recent appointment on record is 12 Dec 2016 at Omsav Pharma Research Private Limited.
Himadri Sen held 2 earlier board appointments: Unimark Remedies Limited (Whole-Time Director, 21 Sep 2010 to 15 Apr 2013); Steerlife India Private Limited (Director, from 14 Jul 2015).
The current boards of Himadri Sen's companies include Kewal Kundanlal Handa (Omsav Pharma Research Private Limited), Om Dutt Tyagi (Omsav Pharma Research Private Limited), Ranchodlal Keshavlal Shah (Omsav Pharma Research Private Limited), Savita Tyagi (Omsav Pharma Research Private Limited), Tushar Srivastava Kumar (Omsav Pharma Research Private Limited).